1型糖尿病中炎症与内皮功能障碍生物标志物对脉压及高血压发病的预测:一项20年生命历程起始队列研究
在277例1型糖尿病起始队列中,基线及随访20年反复检测CRP、sICAM-1、sVCAM-1和sE-selectin,采用广义估计方程分析其与脉压及高血压的关系。sICAM-1和sVCAM-1较高水平与后续脉压升高显著相关;sVCAM-1较高水平与高血压患病及发病显著相关。作者认为血管内皮功能障碍和炎症可能参与1型糖尿病早期动脉僵硬和高血压的发生。
要点
- sICAM-1和sVCAM-1较高水平与后续脉压升高显著相关,CRP和sE-selectin无此关联。
- 基线及随访中sVCAM-1较高水平与高血压患病及发病显著相关。
- 未发现血压或高血压反向预测这些生物标志物变化的证据。
核心结论
- 这些发现支持血管内皮功能障碍和炎症参与1型糖尿病早期动脉僵硬和高血压的发生。
研究设计与样本
- 在277例1型糖尿病起始队列中,基线及起病后反复检测生物标志物至20年,采用广义估计方程分析,并调整年龄、性别、吸烟状态、BMI、HbA1c、血清肌酐、总胆固醇、尿白蛋白排泄率、胰岛素治疗剂量和平均动脉压。
主要发现
- 除sE-selectin随时间下降外,其余生物标志物均升高,且在起病后2-4年即与基线水平不同,早于起病后8-10年出现的脉压升高。
- 基线和20年随访中较高的sICAM-1和sVCAM-1水平与后续时间点较高的脉压(变化)显著相关,CRP和sE-selectin无此关联。
- 基线和随访中较高的sVCAM-1水平与高血压患病显著相关,OR分别为3.60(95%CI 1.36,9.53)和2.28(95%CI 1.03,5.25)。
- 基线和随访中较高的sVCAM-1水平与高血压发病显著相关,OR分别为2.89(95%CI 1.08,7.75)和3.06(95%CI 1.01,9.26)。
- 分析血压或高血压作为后续CRP、sICAM-1、sVCAM-1和sE-selectin水平(变化)的决定因素,未发现支持反向因果假设的证据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Vascular inflammation and endothelial dysfunction are thought to contribute to arterial stiffening and hypertension. This study aims to test this hypothesis with longitudinal data in the context of type 1 diabetes. METHODS: We investigated, in an inception cohort of 277 individuals with type 1 diabetes, the course, tracking and temporal inter-relationships of BP, specifically pulse pressure (a marker of arterial stiffening) and hypertension, and the following biomarkers of systemic and vascular inflammation/endothelial dysfunction: C-reactive protein (CRP), soluble intracellular adhesion molecule-1 (sICAM-1), soluble vascular cellular adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin). These biomarkers and other risk factors were measured at baseline and repeatedly up to 20 years after the onset of type 1 diabetes. Data were analysed with generalised estimating equations including adjustments for age, sex, smoking status, BMI, HbA1c, serum creatinine, total cholesterol, urinary AER, insulin treatment dose and mean arterial pressure. RESULTS: Increases were noted in all biomarkers except sE-selectin, which decreased over time. Levels differed from baseline at 2-4 years and preceded the increase in pulse pressure, which occurred at 8-10 years after the onset of type 1 diabetes. Higher levels of sICAM-1 and sVCAM-1, but not CRP or sE-selectin, at baseline and throughout the 20 year follow-up, were significantly associated with higher (changes in) pulse pressure at subsequent time points. Higher levels of sVCAM-1 at baseline and during follow-up were also significantly associated with the prevalence (OR 3.60 [95% CI 1.36, 9.53] and OR 2.28 [1.03, 5.25], respectively) and incidence (OR 2.89 [1.08, 7.75] and OR 3.06 [1.01, 9.26], respectively) of hypertension. We also investigated the longitudinal associations between BP or hypertension as determinants of subsequent (changes in) levels of CRP, sICAM-1, sVCAM-1 and sE-selectin, but did not find evidence to support a reverse causality hypothesis. CONCLUSIONS/INTERPRETATION: These findings support the involvement of vascular endothelial dysfunction and inflammation in the development of premature arterial stiffening and hypertension in type 1 diabetes.
引用
- Ferreira I, Hovind P, Schalkwijk CG, et al. Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort. Diabetologia. 2017. PMID: 29101422. doi:10.1007/s00125-017-4470-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。